GOOD DAY FOR: A drug war, as Pfizer, the world’s largest drugmaker, is considering a counteroffer for Indian generics giant Ranbaxy Laboratories, the Business Standard newspaper reported. Japan’s Daiichi Sankyo bid $4.6 billion for Ranbaxy earlier this week. A Ranbaxy spokesman called the report “speculation,” adding, “We have a binding contract with Daiichi. It is a final contract.” (Reuters)
BAD DAY FOR: Overpacking, after United Airlines and US Airways both said they will charge $15 for passengers’ first checked bag, following American Airlines’ lead. Most U.S. airlines, except for Southwest, already charge $25 for checking a second piece of luggage. US Airways also said it will cut 1,700 jobs, shrink its fleet, and start charging for all in-flight beverages. (AP in Yahoo! Finance)
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
The Icelandic women’s strike 50 years onIn The Spotlight The nation is ‘still no paradise’ for women, say campaigners
-
Mall World: why are people dreaming about a shopping centre?Under The Radar Thousands of strangers are dreaming about the same thing and no one sure why
-
Why scientists are attempting nuclear fusionThe Explainer Harnessing the reaction that powers the stars could offer a potentially unlimited source of carbon-free energy, and the race is hotting up
